News
Pharma firms will face 15% tariffs in Trump’s E.U. trade deal
WASHINGTON — President Trump’s tariffs on pharmaceuticals coming from the European Union will be set at 15% and will not go into effect until a national security investigation has been completed, according to a White House official familiar with the plans.
An EU pharma lobby has criticized the Trump administration’s plans to impose 15% tariffs on pharmaceutical imports amid uncertainty over how the newly announced U.S.-EU trade deal targets the product ...
Many pharmaceutical products made in Europe will face a 15 percent tariff, pinching manufacturers and potentially leading to ...
Americans cannot absorb billions in added drug price hikes as a result of ill-designed and poorly timed tariff increases.
With 1 August fast approaching, we expect the Trump administration to announce pharmaceutical tariffs soon. We anticipate an ...
Trump pharma and chip tariffs may start this month, sparking price hikes, inflation, and global trade ripples.
GSK is expected to report profit of £4.4 billion for the first half of this year. AstraZeneca is forecast to report a ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even ...
Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.
President Donald Trump said Tuesday he’s imposing a new 50% tariff on all copper. However, it’s unclear when the new tariff ...
Trump announced significant increases to import tariffs: a 50% tariff on copper and a planned 200% tariff on pharmaceuticals, the latter to take effect after a one-year delay.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback